drugset / Trial / NCT02980562

Comparison of Low Volume PEG-Asc and Lower Volume PEG-Asc With Bisacodyl

NCT02980562

Phase 3 Completed 200 enrolled Korea University Anam Hospital
RandomizedParallel-groupSingle-blind

Summary

Recently a low-volume polyethylene glycol containing ascorbic acid (PEG-Asc) formulation has proven as safe and effective as traditional 4-L PEG solutions for colonoscopy preparation. However, currently available aqueous purgative formulations are poorly tolerated. The aim of this study was to compare a split-dose 2-L PEG-Asc and a 1-L PEG-Asc with bisacodyl (10 mg) formulation to determine the quality of bowel cleansing and patient tolerability.

Timeline

Start
2015-05
Primary completion
2015-09
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bisacodyl Small molecule 10 mg
Comparator Polyethylene Glycols Unknown 1000 ml Oral

Indications